Researcher Paul Hergenrother and colleagues improved upon their earlier research that involved development of a small molecule called ErSo which had the potential to kill ER+ breast cancer cells but ...
Researcher Paul Hergenrother and colleagues improved upon their earlier research that involved development of a small molecule called ErSo which had the potential to kill ER+ breast cancer cells ...
Jan. 15, 2025 — In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive ...
Researchers have developed light-sensitive chemicals that can eliminate tumors in vivo in mouse models of breast cancer with minimal side effects. | Drug Discovery And Development ...